v3.23.3

Share Data and Net Assets (Tables) | 12 Months Ended
--- | ---
Sep. 30, 2023
Stockholders' Equity Note [Abstract] |
Schedule of Basic and Diluted Earnings Per Share | The following table sets forth the computation of basic and diluted earnings per share, pursuant to ASC Topic 260-10, Earnings per Share, for the years ended September 30, 2023, 2022 and 2021:
(Share amounts in thousands) |  | Year ended September 30, 2023 |  | Year ended September 30, 2022 |  | Year ended September 30, 2021
Earnings (loss) per common share — basic and diluted: |  |  |  |  |  |
Net increase (decrease) in net assets resulting from operations |  | $ | 117,331 |  |  | $ | 29,223 |  |  | $ | 237,260 |
Weighted average common shares outstanding — basic and diluted |  | 72,119 |  |  | 60,727 |  |  | 54,039 |
Earnings (loss) per common share — basic and diluted |  | $ | 1.63 |  |  | $ | 0.48 |  |  | $ | 4.39 |
Schedule of Changes in Net Assets | The following table presents the changes in net assets for the years ended September 30, 2023, 2022 and 2021:
|  | Common Stock |  |  |  |  |  |
(Share amounts in thousands) |  | Shares |  | Par Value |  | Additional paid-in-capital |  | Accumulated Overdistributed Earnings |  | Total Net Assets
Balance as of September 30, 2020 |  | 46,987 |  |  | $ | 470 |  |  | $ | 1,488,713 |  |  | $ | (574,304) |  |  | $ | 914,879 |
Net investment income |  | — |  |  | — |  | — |  | 97,106 |  | 97,106
Net unrealized appreciation (depreciation) |  | — |  | — |  | — |  | 114,519 |  | 114,519
Net realized gains (losses) |  | — |  | — |  | — |  | 26,420 |  | 26,420
(Provision) benefit for taxes on realized and unrealized gains (losses) |  | — |  | — |  | — |  | (785) |  | (785)
Distributions to stockholders |  | — |  | — |  | — |  | (82,020) |  | (82,020)
Reclassification of additional paid-in capital |  | — |  | — |  | 74,271 |  | (74,271) |  | —
Issuance of common stock in connection with the OCSI Merger |  | 13,133 |  | 131 |  | 242,573 |  | — |  | 242,704
Issuance of common stock under dividend reinvestment plan |  | 113 |  | 1 |  | 2,169 |  | — |  | 2,170
Repurchases of common stock under dividend reinvestment plan |  | (113) |  | (1) |  | (2,169) |  | — |  | (2,170)
Balance as of September 30, 2021 |  | 60,120 |  |  | 601 |  |  | 1,805,557 |  |  | (493,335) |  |  | 1,312,823 |
Net investment income |  | — |  |  | — |  | — |  | 148,621 |  | 148,621
Net unrealized appreciation (depreciation) |  | — |  | — |  | — |  | (136,248) |  | (136,248)
Net realized gains (losses) |  | — |  | — |  | — |  | 17,179 |  | 17,179
(Provision) benefit for taxes on realized and unrealized gains (losses) |  | — |  | — |  | — |  | (329) |  | (329)
Distributions to stockholders |  | — |  | — |  | — |  | (118,657) |  | (118,657)
Issuance of common stock in connection with the "at the market" offering |  | 934 |  | 9 |  | 20,613 |  | — |  | 20,622
Issuance of common stock under dividend reinvestment plan |  | 166 |  | 2 |  | 3,407 |  | — |  | 3,409
Repurchase of common stock under dividend reinvestment plan |  | (95) |  | (1) |  | (1,856) |  | — |  | (1,857)
Balance as of September 30, 2022 |  | 61,125 |  |  | 611 |  |  | 1,827,721 |  |  | (582,769) |  |  | 1,245,563 |
Net investment income |  | — |  |  | — |  | — |  | 180,697 |  | 180,697
Net unrealized appreciation (depreciation) |  | — |  | — |  | — |  | (28,555) |  | (28,555)
Net realized gains (losses) |  | — |  | — |  | — |  | (33,155) |  | (33,155)
(Provision) benefit for taxes on realized and unrealized gains (losses) |  | — |  | — |  | — |  | (1,656) |  | (1,656)
Distributions to stockholders |  | — |  | — |  | — |  | (185,900) |  | (185,900)
Issuance of common stock in connection with the OSI2 Merger |  | 15,860 |  | 159 |  | 333,875 |  | — |  | 334,034
Issuance of common stock in connection with the "at the market" offering |  | 69 |  | 1 |  | 1,299 |  | — |  | 1,300
Issuance of common stock under dividend reinvestment plan |  | 297 |  | 3 |  | 5,851 |  | — |  | 5,854
Repurchase of common stock under dividend reinvestment plan |  | (126) |  | (2) |  | (2,416) |  | — |  | (2,418)
Balance as of September 30, 2023 |  | 77,225 |  |  | $ | 772 |  |  | $ | 2,166,330 |  |  | $ | (651,338) |  |  | $ | 1,515,764 |
Schedule of Distributions | The following table reflects the distributions per share that the Company has paid, including shares issued under the DRIP, on its common stock during the years ended September 30, 2023, 2022 and 2021:
Distribution |  | Date Declared |  | Record Date |  | Payment Date |  | Amount per Share |  | Cash Distribution (3) |  | DRIP Shares Issued |  | DRIP Shares Value (3) |  |
Quarterly |  | November 10, 2022 |  | December 15, 2022 |  | December 30, 2022 |  | $ | 0.54 |  |  | $ | 32.0 | million |  | 53,369 |  | (1) | $ | 1.1 | million |  |
Special |  | November 10, 2022 |  | December 15, 2022 |  | December 30, 2022 |  | 0.42 |  |  | 24.8 | million |  | 41,510 |  | (1) | 0.8 | million |  |
Quarterly |  | January 27, 2023 |  | March 15, 2023 |  | March 31, 2023 |  | 0.55 |  |  | 41.1 | million |  | 68,412 |  | (2) | 1.3 | million |  |
Quarterly |  | April 28, 2023 |  | June 15, 2023 |  | June 30, 2023 |  | 0.55 |  |  | 41.3 | million |  | 57,279 |  | (2) | 1.1 | million |  |
Quarterly |  | July 28, 2023 |  | September 15, 2023 |  | September 29, 2023 |  | 0.55 |  |  | 40.9 | million |  | 76,766 |  | (1) | 1.5 million |  |
Total for the year ended September 30, 2023 |  | $ | 2.61 |  |  | $ | 180.0 | million |  | 297,336 |  |  | $ | 5.9 | million |  |
Distribution |  | Date Declared |  | Record Date |  | Payment Date |  | Amount per Share |  | Cash Distribution |  | DRIP Shares Issued |  | DRIP Shares Value (3) |  |
Quarterly |  | October 13, 2021 |  | December 15, 2021 |  | December 31, 2021 |  | $ | 0.465 |  |  | $ | 27.2 | million |  | 35,990 |  | (1) | $ | 0.8 | million |  |
Quarterly |  | January 28, 2022 |  | March 15, 2022 |  | March 31, 2022 |  | 0.48 |  |  | 28.5 | million |  | 34,804 |  | (1) | 0.8 | million |  |
Quarterly |  | April 29, 2022 |  | June 15, 2022 |  | June 30, 2022 |  | 0.495 |  |  | 29.4 | million |  | 43,676 |  | (2) | 0.9 | million |  |
Quarterly |  | July 29, 2022 |  | September 15, 2022 |  | September 30, 2022 |  | 0.51 |  |  | 30.2 | million |  | 51,181 |  | (2) | 1.0 | million |  |
Total for the year ended September 30, 2022 |  | $ | 1.95 |  |  | $ | 115.3 | million |  | 165,651 |  |  | $ | 3.4 | million |  |
Distribution |  | Date Declared |  | Record Date |  | Payment Date |  | Amount per Share |  | Cash Distribution |  | DRIP Shares Issued |  | DRIP Shares Value (3) |  |
Quarterly |  | November 13, 2020 |  | December 15, 2020 |  | December 31, 2020 |  | $ | 0.33 |  |  | $ | 15.0 | million |  | 31,321 |  | (2) | $ | 0.5 | million |  |
Quarterly |  | January 29, 2021 |  | March 15, 2021 |  | March 31, 2021 |  | 0.36 |  |  | 16.4 | million |  | 27,234 |  | (2) | 0.5 | million |  |
Quarterly |  | April 30, 2021 |  | June 15, 2021 |  | June 30, 2021 |  | 0.39 |  |  | 22.9 | million |  | 25,660 |  | (2) | 0.5 | million |  |
Quarterly |  | July 30, 2021 |  | September 15, 2021 |  | September 30, 2021 |  | 0.435 |  |  | 25.5 | million |  | 28,358 |  | (2) | 0.6 | million |  |
Total for the year ended September 30, 2021 |  | $ | 1.515 |  |  | $ | 79.8 | million |  | 112,573 |  |  | $ | 2.2 | million |  |
__________ (1) New shares were issued and distributed. (2) Shares were purchased on the open market and distributed. (3) Totals may not sum due to rounding.
Schedule of Common Stock Issued and Sold | In connection with the "at the market" offering, the Company issued and sold 68,752 shares of common stock during the year ended September 30, 2023 for net proceeds of $1.3 million (net of offering costs).
|  | Number of Shares Issued |  | Gross Proceeds |  | Placement Agent Fees |  | Net Proceeds (1) |  | Average Sales Price per Share (2)
"At the market" offering |  | 68,752 |  |  | $ | 1,384 |  |  | $ | 14 |  |  | $ | 1,370 |  |  | $ | 20.13 |
(1) Net proceeds excludes offering costs of $0.1 million. (2) Represents the gross sales price before deducting placement agent fees and estimated offering expenses. In connection with the "at the market" offering, the Company issued and sold 933,733 shares of common stock during the year ended September 30, 2022 for net proceeds of $20.6 million (net of offering costs).
|  | Number of Shares Issued |  | Gross Proceeds |  | Placement Agent Fees |  | Net Proceeds (1) |  | Average Sales Price per Share (2)
"At the market" offering |  | 933,733 |  |  | $ | 21,049 |  |  | $ | 210 |  |  | $ | 20,839 |  |  | $ | 22.54 |
__________ (1) Net proceeds excludes offering costs of $0.2 million. (2) Represents the gross sales price before deducting placement agent fees and estimated offering expenses.

X
- Definition Tabular disclosure of information related to dividends declared, including paid and unpaid dividends. + References No definition available. + Details
Name: | us-gaap_DividendsDeclaredTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of change in net assets (equity) of investment company. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 205 -Name Accounting Standards Codification -Section 45 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481004/946-505-50-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2 Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2 Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480555/946-210-45-3 + Details
Name: | us-gaap_InvestmentCompanyChangesInNetAssetsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of sales of stock or previously unissued stock made by subsidiary or equity method investee to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration